3.3.0.814 html 104 160 1 false 44 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.immunedesign.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Balance Sheets Sheet http://www.immunedesign.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Balance Sheets (Parenthetical) Sheet http://www.immunedesign.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Statements of Operations Sheet http://www.immunedesign.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 1003000 - Statement - Statements of Cash Flows Sheet http://www.immunedesign.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 5 false false R6.htm 2101100 - Disclosure - Description of the Business Sheet http://www.immunedesign.com/role/DescriptionOfBusiness Description of the Business Notes 6 false false R7.htm 2104100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 2107100 - Disclosure - Net Loss Per Share Sheet http://www.immunedesign.com/role/NetLossPerShare Net Loss Per Share Notes 8 false false R9.htm 2110100 - Disclosure - Fair Value of Financial Instruments Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 9 false false R10.htm 2113100 - Disclosure - Inventory Sheet http://www.immunedesign.com/role/Inventory Inventory Notes 10 false false R11.htm 2116100 - Disclosure - Accrued Liabilities Sheet http://www.immunedesign.com/role/AccruedLiabilities Accrued Liabilities Notes 11 false false R12.htm 2119100 - Disclosure - Commitments and Contingencies Sheet http://www.immunedesign.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 2122100 - Disclosure - Series C Convertible Preferred Stock Warrant Liability Sheet http://www.immunedesign.com/role/SeriesCConvertiblePreferredStockWarrantLiability Series C Convertible Preferred Stock Warrant Liability Notes 13 false false R14.htm 2125100 - Disclosure - License and Collaboration Agreements Sheet http://www.immunedesign.com/role/LicenseAndCollaborationAgreements License and Collaboration Agreements Notes 14 false false R15.htm 2128100 - Disclosure - Stockholders' Equity Sheet http://www.immunedesign.com/role/StockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 2131100 - Disclosure - Legal Proceedings Sheet http://www.immunedesign.com/role/LegalProceedings Legal Proceedings Notes 16 false false R17.htm 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.immunedesign.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 2307301 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.immunedesign.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.immunedesign.com/role/NetLossPerShare 18 false false R19.htm 2310301 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.immunedesign.com/role/FairValueOfFinancialInstruments 19 false false R20.htm 2313301 - Disclosure - Inventory (Tables) Sheet http://www.immunedesign.com/role/InventoryTables Inventory (Tables) Tables http://www.immunedesign.com/role/Inventory 20 false false R21.htm 2316301 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.immunedesign.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.immunedesign.com/role/AccruedLiabilities 21 false false R22.htm 2328301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.immunedesign.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.immunedesign.com/role/StockholdersEquity 22 false false R23.htm 2401401 - Disclosure - Description of the Business - Narrative (Details) Sheet http://www.immunedesign.com/role/DescriptionOfBusinessNarrativeDetails Description of the Business - Narrative (Details) Details 23 false false R24.htm 2404402 - Disclosure - Summary of Significant Accounting Policies - Segments (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesSegmentsDetails Summary of Significant Accounting Policies - Segments (Details) Details 24 false false R25.htm 2404403 - Disclosure - Summary of Significant Accounting Policies - Reverse Stock Split (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesReverseStockSplitDetails Summary of Significant Accounting Policies - Reverse Stock Split (Details) Details 25 false false R26.htm 2404404 - Disclosure - Summary of Significant Accounting Policies - Follow-On Public Offering (Details) Sheet http://www.immunedesign.com/role/SummaryOfSignificantAccountingPoliciesFollowOnPublicOfferingDetails Summary of Significant Accounting Policies - Follow-On Public Offering (Details) Details 26 false false R27.htm 2407402 - Disclosure - Net Loss Per Share - Common Stock Issuable Upon the Conversion or Exercise of Dilutive Securities Excluded from Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Sheet http://www.immunedesign.com/role/NetLossPerShareCommonStockIssuableUponConversionOrExerciseOfDilutiveSecuritiesExcludedFromDilutedNetLossPerShareAttributableToCommonStockholdersDetails Net Loss Per Share - Common Stock Issuable Upon the Conversion or Exercise of Dilutive Securities Excluded from Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Details 27 false false R28.htm 2410402 - Disclosure - Fair Value of Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.immunedesign.com/role/FairValueOfFinancialInstrumentsFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value of Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 28 false false R29.htm 2413402 - Disclosure - Inventory (Details) Sheet http://www.immunedesign.com/role/InventoryDetails Inventory (Details) Details http://www.immunedesign.com/role/InventoryTables 29 false false R30.htm 2416402 - Disclosure - Accrued Liabilities (Details) Sheet http://www.immunedesign.com/role/AccruedLiabilitiesDetails Accrued Liabilities (Details) Details http://www.immunedesign.com/role/AccruedLiabilitiesTables 30 false false R31.htm 2419401 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.immunedesign.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 31 false false R32.htm 2422401 - Disclosure - Series C Convertible Preferred Stock Warrant Liability (Details) Sheet http://www.immunedesign.com/role/SeriesCConvertiblePreferredStockWarrantLiabilityDetails Series C Convertible Preferred Stock Warrant Liability (Details) Details http://www.immunedesign.com/role/SeriesCConvertiblePreferredStockWarrantLiability 32 false false R33.htm 2425401 - Disclosure - License and Collaboration Agreements - Narrative (Details) Sheet http://www.immunedesign.com/role/LicenseAndCollaborationAgreementsNarrativeDetails License and Collaboration Agreements - Narrative (Details) Details 33 false false R34.htm 2428402 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 34 false false R35.htm 2428403 - Disclosure - Stockholders' Equity - Schedule of Shares of Common Stock Reserved for Future Issuance (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityScheduleOfSharesOfCommonStockReservedForFutureIssuanceDetails Stockholders' Equity - Schedule of Shares of Common Stock Reserved for Future Issuance (Details) Details 35 false false R36.htm 2428404 - Disclosure - Stockholders' Equity - Summary of Stock Options (Details) Sheet http://www.immunedesign.com/role/StockholdersEquitySummaryOfStockOptionsDetails Stockholders' Equity - Summary of Stock Options (Details) Details 36 false false R37.htm 2428405 - Disclosure - Stockholders' Equity - Schedule of Stock-Based Compensation Expense Recognized (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityScheduleOfStockBasedCompensationExpenseRecognizedDetails Stockholders' Equity - Schedule of Stock-Based Compensation Expense Recognized (Details) Details 37 false false R38.htm 2428406 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Stock Options Granted to Employees (Details) Sheet http://www.immunedesign.com/role/StockholdersEquityScheduleOfFairValueOfStockOptionsGrantedToEmployeesDetails Stockholders' Equity - Schedule of Fair Value of Stock Options Granted to Employees (Details) Details 38 false false R39.htm 2431401 - Disclosure - Legal Proceedings (Details) Sheet http://www.immunedesign.com/role/LegalProceedingsDetails Legal Proceedings (Details) Details http://www.immunedesign.com/role/LegalProceedings 39 false false All Reports Book All Reports In ''Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Statements of Cash Flows'', column(s) 1, 2, 3 are contained in other reports, so were removed by flow through suppression. imdz-20150930.xml imdz-20150930_cal.xml imdz-20150930_def.xml imdz-20150930_lab.xml imdz-20150930_pre.xml imdz-20150930.xsd true true